tykhr
sign in
free sign up
Ayala Pharmaceuticals Inc
Biotechnology
Healthcare
AYLA
15.30 M shares
NASDAQ US
traded
16 Sep 2022
listed
yes
open
1.37
52 week high
14.09
high
1.53
52 week low
1.34
low
1.34
growth
-87.68 %
previous Close
1.37
P/E ratio
market cap
14.23 M
div yield
0
usd
Mar 2022
qoq
revenue
458 K
-60.03 %
net incoming
-10.03 M
0.22 %
eps
0.00 %
0.00 %
eps surprise
2.94 %
net profit margin
-2189.30 %
-1312.00 %
operating incoming
-9.85 M
-0.89 %
net change in cash
-9.94 M
-158.52 %
cash on hand
27.05 M
-26.86 %
cost of revenue
368 K
-67.89 %
top